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Abstract
 
The finding that 
 
Treponema pallidum
 
, the syphilis spirochete, contains 12 orthologs of the 
 
Trepo-
nema denticola
 
 outer membrane major sheath protein has engendered speculation that members
of this 
 
T. pallidum
 
 repeat (Tpr) family may be similarly surface exposed. In this regard, the
TprK protein was reported to be a target of opsonic antibody and protective immunity and
subject to immunologically driven sequence variation. Despite these findings, results from our
previous analyses of treponemal outer membranes in concert with computer-based predictions
for TprK prompted us to examine the cellular location of this protein. TprK–alkaline phos-
phatase fusions expressed in 
 
Escherichia
 
 
 
coli
 
 demonstrate that TprK contains a signal peptide.
However, opsonophagocytosis assays failed to indicate surface exposure of TprK. Moreover,
results from three independent methodologies, i.e., (a) indirect immunofluorescence analysis of
agarose-encapsulated organisms, (b) proteinase K treatment of intact spirochetes, and (c) Triton
X-114 phase partitioning of 
 
T. pallidum 
 
conclusively demonstrated that native TprK is entirely
periplasmic
 
.
 
 Consistent with this location, immunization with the recombinant protein failed
to induce either protective immunity or select for TprK variants in the rabbit model of experi-
mental syphilis. These findings challenge the notion that TprK will be a component of an effi-
cacious syphilis vaccine.
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Introduction
 
In recent years, the quest for outer membrane (OM)
 
1
 
 pro-
teins of 
 
Treponema pallidum
 
 as potential virulence determi-
nants and vaccinogens has become a major focus of syphilis
research. The many methodological difficulties inherent in
this search, coupled with our limited knowledge of 
 
T. palli-
dum
 
 OM constituents, has spawned a variety of experimen-
tal approaches for identifying these proteins (1–4). How-
ever, to date none of these strategies has yielded a
polypeptide which is universally accepted as being surface
exposed. The availability of the 
 
T. pallidum
 
 genomic se-
quence has opened new avenues in this search (5). Indeed,
one of the most important discoveries is that 
 
T. pallidum
 
contains 12 orthologs (designated 
 
T. pallidum
 
 repeat [Tpr]
proteins) for the surface-exposed major sheath protein
(Msp) of the oral commensal spirochete 
 
Treponema denticola
 
(5), an abundant 55-kD polypeptide which reportedly
forms a hexagonal array in the 
 
T. denticola
 
 OM and pos-
sesses porin-like activity (6). Consistent with this implied
cellular location, Centurion-Lara et al. (7) reported that the
 
T. pallidum 
 
Tpr paralog designated TprK is a target for op-
sonic Ab and that immunization with the recombinant
protein conferred partial protection in the rabbit model of
experimental syphilis. The subsequently reported sequence
variability of 
 
tprK 
 
among 
 
T. pallidum
 
 clinical isolates and
within “subpopulations” of street and laboratory strains also
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 GlpQ, glycerophosphodiester phospho-
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Treponema pallidum
 
 repeat. 
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was believed to be consistent with the accessibility of TprK
to Ab (8, 9). Moreover, the considerable number of Tpr
paralogs has engendered speculation that recombination
among these genes provides a means of escaping host im-
mune responses (5, 7, 10).
Despite the above findings, several considerations sug-
gested to us that further examination of the cellular loca-
tion of TprK was warranted. First, partial protection from
challenge with virulent treponemes is not in and of itself
indicative of surface location because similar levels of pro-
tection have been obtained with Ags which are not surface
exposed (11). Second, although opsonophagocytosis assays
are theoretically capable of identifying surface-exposed 
 
T.
pallidum
 
 Ags, results with this assay have not always corre-
lated with other surface localization methodologies (12,
13). Third, in our own studies (13, 14) using a photoacti-
vatable lipophilic probe (3-(trifluoromethy-)-3-(
 
m
 
-[
 
125
 
I]io-
dophenyl-diazarene) which promiscuously labels integral
membrane proteins, we were unable to detect a radiola-
beled protein corresponding to TprK when either intact
spirochetes or isolated 
 
T. pallidum
 
 OMs were incubated
with this compound. Fourth, in a recent study, we found
that Msp is predominantly periplasmic in 
 
T. denticola
 
 and
does not appear to form OM hexagonal rays as reported
previously (15). Lastly, results from computer analyses lend
only marginal support to the notion that this polypeptide
resides in the OM. PSORT (http://psort.nibb.ac.jp/
form.html) predicts that TprK could be either a periplasmic
(PP) or an OM protein (7); the localization scores heavily
favor a PP location. TMpred (http://www.ch.embnet.org/
software/TMPRED_form.html), on the other hand, pre-
dicts that TprK contains an 
 
a
 
-helical transmembrane do-
main downstream of the presumptive signal peptide which,
if present, would prevent translocation of the nascent
polypeptide across the cytoplasmic membrane (16).
Here we used a battery of genetic, biological, and protein-
based approaches to study the cellular location of TprK in 
 
T.
pallidum
 
. Our data unambiguously demonstrate that TprK is
a periplasmic protein. Consistent with this compartmental
assignment, immunization of rabbits with TprK failed to in-
duce either opsonic Abs or protective immunity. Equally
important, we found that the 
 
tprK
 
 gene was unaltered in
treponemes recovered from TprK-immunized animals, indi-
cating that sequence variation of TprK is not immunologi-
cally driven. These findings challenge the notion that TprK
will be a component of an efficacious syphilis vaccine.
 
Materials and Methods
 
Bacterial Strains
 
Treponema pallidum 
 
subspecies 
 
pallidum
 
 strain was propagated by
intratesticular inoculation of adult New Zealand White rabbits as
described previously (17). Animal protocols described in this
work were approved by the University of Connecticut Health
Center Animal Care Committee under the auspices of Animal
Welfare Assurance no. A3471-01. 
 
Escherichia coli 
 
strain DH5
 
a
 
 was
the recipient strain for recombinant constructs and was grown in
Luria-Bertani (LB) broth with appropriate antibiotic supplemen-
tation.
 
Transcriptional Analysis of the tpr Genes
 
Determination of Primer Efficiency.
 
The amplification effi-
ciency of the primer pairs used for reverse transcription (RT)-
PCR was determined with limiting dilutions of 
 
T. pallidum
 
 DNA
using amplification conditions identical to those used in the RT-
PCR experiments (see below). The densitometric signal of the
resolved 
 
tpr
 
 PCR products, measured by an Alpha Innotech
ChemiImager 4400 (Alpha Innotech Corporation), was divided
by the signal of the 
 
fla
 
 PCR product amplified from equivalent
amounts of DNA, and expressed as the efficiency of the primer
pair (Table I).
 
RT-PCR.
 
With the following exceptions, RNA isolation
and RT-PCR were performed as described previously (18). For
each RT-PCR primer pair, four types of reactions were per-
formed: (a) RT-PCR with log-dilutions of RNA ranging from
100 ng to 10 pg, (b) PCR with 100 ng of RNA, (c) RT-PCR
with water only, and (d) PCR with 5 ng of DNA. After the RT
reaction (50
 
8
 
C for 30 min), PCR was performed using the fol-
lowing parameters: 94
 
8
 
C for 3 min followed by 10 cycles of 94
 
8
 
C
for 30 s, 63
 
8
 
C for 30 s, 68
 
8
 
C for 45 s, followed by 25 identical
cycles incorporating an extension time increase of 5 s/cycle fol-
lowed by a single terminal extension for 7 min at 68
 
8
 
C. The den-
sitometric signal of the resolved products was divided by the
primer pair efficiency; the resulting value was subsequently di-
vided by the signal of the 
 
fla
 
 RT-PCR product amplified from
equivalent amounts of 
 
T. pallidum
 
 RNA. Expressed data are
therefore quantitatively corrected for primer efficiency and nor-
malized to
 
 flaA
 
 transcript levels.
 
Construction of PhoA Fusions
 
The plasmids pKS/pho and pSK/pho containing the leader-
less alkaline phosphatase (
 
phoA
 
) gene of 
 
E. coli
 
 in the multiple
cloning site of pBluescript have been described previously (19).
Using primers K1-5
 
9
 
, K2-5
 
9
 
, K3-5
 
9
 
, and K1-3
 
9
 
, three in-frame
 
tpr
 
K–
 
pho
 
A fusions were generated by amplifying and cloning
DNA containing codons 21 through 61 of the TprK open read-
ing frame (ORF) along with various amounts of upstream DNA
into the Xba1 and BamH1 sites of pKS/phoA and pSK/phoA. 
 
E.
coli
 
 clones harboring sequenced PhoA constructs were plated on
LB agar containing 100 
 
m
 
g/ml of ampicillin and 40 
 
m
 
g/ml of
5-bromo-4-chloro-3-indolyl phosphate (Sigma-Aldrich).
 
Production and Purification of Recombinant Proteins
 
Two polyhistidine-tagged rTprK expression constructs were
generated. The first encodes the full-length TprK protein down-
stream of a putative signal peptidase I cleavage site (LWA
 
¯
 
Q).
The second encodes the central region (amino acids 36–350) of
TprK as per Centurion-Lara et al
 
. 
 
(7). Although this region was
originally annotated as the “variable” domain (7), we refer to it as
the “central” domain to avoid confusion with the recently de-
scribed seven discrete regions of variability (V1–V7) present in
different TprK alleles (8, 9). DNAs encoding the TprK full-
length protein and central domain were amplified from Nichols-
Farmington 
 
T. pallidum
 
 DNA using primer pairs K-full-5
 
9
 
/
K-full-3
 
9
 
 and K-cen-5
 
9
 
/K-cen-3
 
9
 
, respectively, and cloned into
EcoR1/BamH1-digested pProEx-Htb (GIBCO BRL). DNA
encoding the mature FlaA protein was amplified with primers
FlaA-5
 
9
 
 and FlaA-3
 
9
 
 and cloned into BamH1 cut pProEx-Hta
(GIBCO BRL). Recombinant TprK clones were completely se-
quenced in both directions to verify the identity and fidelity of
the cloned PCR products; for both the full-length and central
domain fusions, the deduced amino acid sequences were identical
to those of 
 
T. pallidum
 
 (Nichols-Farmington) TprK (see Fig. 8). 
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Table I.
 
Primers Used in This Study
 
Purpose Name 5
 
9
 
 to 3
 
9
 
 sequence Efficiency
 
*
 
RT-PCR flaA-RT-5
 
9
 
TGAATTATCCTCATGGTTTGTACGTG
 
1.00
flaA-RT-3
 
9
 
TCAGCACCGCCTTATCATAGATAATC
 
A-RT-5
 
9
 
TCTCGCTGACGCTTTGTCCACCG
 
1.33
A-RT-3
 
9
 
AAAGTCAAAACCTAGCCCGGAATTC
 
B-RT-5
 
9
 
ACAGAACTGGACCTGATCAGACGCAT
 
1.50
B-RT-3
 
9
 
AGGCTTTCCCTGCGTTATAGGAGG
 
C/D-RT-5
 
9
 
TCAGACCCAAGAGAGAGCTATCCTC
 
0.75
C/D-RT-3
 
9
 
AGCAGTGACAACTCTTGGATCGGA
 
E-RT-5
 
9
 
AGGCTACCGCGGCGATGAGGAC
 
1.08
E-RT-3
 
9
 
GCACTAAGGAAGAAGAGCTTGGTTA
 
F/I-RT-5
 
9
 
TAATCGCCTTCTGGCAACGGGGAG 0.83
F-RT-39 CGTCAGCAAGCACCCCCTGTTC
G-RT-59 GGCAGTGTCAAACGTAAAAGTCACC 0.55
G-RT-39 TTTTTGTTGATCCGGAAGGTTGAAG
H-RT-59 GGTCAGCCATAAACAGAAAAGGCAC 1.18
H-RT-39 ATTTTGGTTGCAATATCCCGCACAG
F/I-RT-59 TAATCGCCTTCTGGCAACGGGGAG 1.55
I-RT-39 AGCACGATGTCCGACTGACTCGG
J-RT-59 ATCTTCACACCCCGCAGGGAAGT 1.18
J-RT-39 ATCTTGCACGCTCACCATGGTCAGA
K-RT-59 TGGGAGCCGTGGACCGCGAATG 1.00
K-RT-39 TCGGGCTTGGGCATAGTCGCTAG
L-RT-59 ACCGCCTGCTGTGGAGCGCCG 0.44
L-RT-39 TGGGTGAGCTGGTTTACCACCGC
PhoA
fusions
K1-59 TTCTAGTCTAGATGATTCCCCTGCGGCACGCCTT‡
K2-59 TTCTAGTCTAGACGCAGTTCCGGATTCTGAatgATTG
K3-59 GTCTAGAATGACGGCATCGGAGAAAAgtgGTGTA
K1-39 GCGGGATCCATCCGGGGTGAACGAAACCTGAG
Protein
expression
K-cen-59 GCGGGATCCGATATTGAAGGCTATGCGGAGCTG
K-cen-39 GCGGAATTCTCAACCCTCAAGGAAAGAAGTATCAGG
K-full-59 GCGGGATCCCAGGTTTCGTTCACCCCGGATATTG
K-full-39 GCGGAATTCTCACCAAATCAAGCGACATGCCCCTAC
FlaA-59 CGGGATCCTGATGAGTCAGTGCTCATCGAC
FlaA-39 CGGGATCCTCTACTGCTGCACTTCCTGCCG
Amplification
of tprK
K1-59 TTCTAGTCTAGATGATTCCCCTGCGGCACGCCTT
Kseq-4 CCACACGCGCCACCTGTGATGGC
TprK59 TTCTGTATTACCTCCGAACCG
TprK39 TGTGATGGCACAAACGTCTAC
Sequencing
of tprK 
amplicons
K1-59 TTCTAGTCTAGATGATTCCCCTGCGGCACGCCTT
K3-59 GTCTAGAATGACGGCATCGGAGAAAAGTGGTGTA
TprK59 TTCTGTATTACCTCCGAACCG
TprK39 TGTGATGGCACAAACGTCTAC
K-RT-59 TGGGAGCCGTGGACCGCGAATG
K-full-39 GCGGAATTCTCACCAAATCAAGCGACATGCCCCTAC
Kseq-5 GTGCGTACGTACATGCCTGTCC
*The flaA normalized primer pair efficiencies were determined by PCR amplification with limiting dilutions of T. pallidum DNA followed by den-
sitometric analysis of band intensities. The measured efficiency of the tprC/D primer pair (1.5) was divided by two as there are two copies of this
template per genome.
‡Underlined sequences indicate restriction sites used for cloning. Naturally occurring and engineered stop codons are italicized, and lowercase
codons indicate translational start sites proposed by Fraser et al. (reference 5; K2-59) and Centurion-Lara et al. (reference 7; K3-59).1018 The Periplasmic Protein TprK Is Not Protective
Fusion proteins were expressed by the addition of isopropyl-
thiogalactopyranoside to 1 mM and purified on a Ni-NTA ma-
trix (QIAGEN) according to the manufacturer’s instructions for
insoluble proteins. The identities of the purified rTprK full-
length and central domain proteins were confirmed by matrix-
assisted laser desorption/ionization time-of-flight mass spectrom-
etry at the Keck Foundation Biotechnology Resource Laboratory
at Yale University.
Immunologic Reagents
Rat anti-TprK antisera were generated by priming Sprague
Dawley rats by intraperitoneal injection with 15 mg of full-length
rTprK protein in CFA. After 1 mo, animals were boosted four
times over 8 wk with a 1:1 mixture of the central domain and
full-length rTprK (15 mg of each protein/boost) in IFA. The
mAb 1-7H11.1G6, directed against full-length rTprK, was pro-
duced at the Hybridoma Center for Agricultural and Biological
Sciences at Oklahoma State University. Rabbits were immunized
with rTprK as described below; sera were collected 10 d after the
final boost. Rat anti-Fla antisera were generated in Sprague-
Dawley rats by intraperitoneal injection with 50 mg/rat of rFlaA
protein in CFA, followed at weeks 6 and 8 by similarly adminis-
tered boosts in IFA. Rat anti-Tp47 and rabbit anti-endoflagella
(TpEf) antisera have been described previously (13, 17, 20).
ELISA for Detection of Anti-TprK Ab
ELISAs were performed as described previously (13). The
wells of microtiter plates coated with dilutions (100 ng/well to 1
pg/well) of full-length, or central domain rTprK were incubated
with 1:50 or 1:1,000 dilutions of either NRS, IRS, IRS depleted
of anti-TprK Ab (see below), rat, or rabbit anti-TprK antisera.
Immunoblot Analysis
SDS-PAGE of samples followed by transfer to nitrocellulose
membranes was preformed as described previously (14). Blots
were incubated with 1:1,000 dilutions of rat antisera or 1:10 dilu-
tions of hybridoma supernatant and subsequently developed by
either colorimetric (FlaA and Tp47) or chemiluminescent (TprK)
methods as described previously (14, 18).
Triton X-114 Phase Partitioning
Freshly extracted T. pallidum was solubilized overnight at 48C
in PBS containing 2% Triton X-114 (octylphenoxypolyethoxy-
ethanol). Insoluble material was removed by centrifugation and
the supernatant was phase separated as described previously (13).
The resulting fractions were analyzed by immunoblot.
Proteinase K Digestion
Proteinase K (PK) digestion was performed as described previ-
ously (13, 21). Freshly isolated T. pallidum were centrifuged at
20,000 g for 15 min and resuspended in PBS containing 1 mM
CaCl2 and 5 mM MgCl2. After addition of either PBS, PK to 0.4
mg/ml, or PK plus Triton X-100 (t-octylphenoxypolyethoxyeth-
anol) to 0.01%, spirochetes were incubated at 378C for 30 min
followed by the addition of PMSF to 1 mg/ml. Lysates of un-
treated, PK-treated, and Triton/PK-treated T. pallidum were ana-
lyzed by immunoblot.
Indirect Immunofluorescence of T. pallidum Encapsulated in
Gel Microdroplets
Preparation of agarose-encapsulated treponemes has been de-
scribed previously (13, 17). To discriminate between surface and
subsurface exposure of TprK by individual spirochetes, encapsu-
lated organisms were simultaneously probed with 1:30 dilutions
of both rat anti-TprK and rabbit anti-TpEf antisera in the absence
or presence of 0.05% Triton X-100. After a 1-h incubation and
three gentle washes, the beads were incubated with 3 mg of bio-
tinylated goat anti–rat IgG, washed, and then incubated with 3 mg
of streptavidin-Alexa® 546 conjugate (Molecular Probes) and 3
mg goat anti–rabbit conjugated to Alexa® 488 (Molecular
Probes). For each condition, two slides from each of three sepa-
rate experiments were prepared, and z100 organisms per slide
were scored for labeling with Alexa® 546 (TprK) and Alexa® 488
(endoflagella). Fluorescence emission overlap did not occur as the
fluorescence of singly labeled organisms (either TprK or TpEf)
was only observed with the appropriate filter.
Opsonophagocytosis Assay
With minor exception, opsonophagocytosis assays were per-
formed as described previously (7, 13, 22). In brief, rabbit perito-
neal macrophages were incubated with T. pallidum (10 organisms
per macrophage) in the presence of 10% heat-inactivated (568C
for 30 min) NRS, IRS, or rabbit anti-TprK antisera. After incu-
bation with T. pallidum, macrophages were washed, fixed, and
processed for immunofluorescence microscopy using HSS and
FITC-conjugated goat anti–human IgG as described previously.
In a separate series of experiments, opsonophagocytosis assays
were performed using IRS from which anti-TprK Ab had been
removed by two sequential rounds of incubation with purified
full-length rTprK. In the first round, 40 mg of pelleted, insoluble
TprK protein was resuspended in 1 ml of pooled IRS as a colloi-
dal solution and incubated for 2 h followed by two 30-min cen-
trifugations at 100,000 g to remove rTprK and bound Ab. The
supernatant was further depleted by incubation with 40 mg of rT-
prK immobilized on a nitrocellulose membrane (Schleicher &
Schuell). After centrifugation at 25,000 g, the supernatant was
quantitatively recovered. Depletion of TprK immunoreactivity
was confirmed by ELISA using both the full-length (see Fig. 3 B,
inset) and central domain (data not shown) recombinant proteins
and by immunoblot analysis (data not shown).
Intradermal Challenge of TprK-immunized Rabbits
Rabbits were immunized over a 2-mo period with a 1:1 mix-
ture of the TprK central domain (125 mg) and full-length protein
(125 mg) per rabbit in Ribi Adjuvant (MPL 1 TDM 1 CWS;
Corixa Corporation) according to the manufacturer’s instruc-
tions. It should be noted that, except for the inclusion of full-
length protein, this immunization protocol was identical to that
of Centurion-Lara et al. (7). The protective capacity of TprK was
evaluated in two separate experiments. In the first, two TprK-
immunized rabbits and two serologically nonreactive control ani-
mals were challenged with 103 virulent treponemes by intrader-
mal injection on their shaved backs at each of six sites. In the
second experiment, identical challenges were administered to
four TprK-immunized and four sham-immunized animals. Ani-
mals were examined daily to monitor the development, morpho-
logic appearance, and progression of lesions which were scored
for erythema, induration, and ulceration. Lesion aspirates were
obtained at designated time points for darkfield microscopy and,
in experiment two, for PCR amplification and sequence analysis
of the tprK gene. At the termination of experiment one (90 d af-
ter challenge), the spleens or popliteal nodes were excised for rab-
bit infectivity testing (RIT; reference 23). After the development
of orchitis or seroconversion, recipient animals were killed and
treponemes were harvested as described above.1019 Hazlett et al.
Nucleotide Sequence Analysis
TprK genes were amplified with primers K1-59/Kseq-4 or
TprK59/TprK39 (Table I) and the Expand High Fidelity PCR
system (Boehringer). PCR was performed as follows: 948C for 2
min followed by 35 cycles of 948C for 10 s, 658C for 10 s, 728C
for 2 min followed by a single terminal extension for 7 min at
728C; products were TA cloned or purified using the Concert
Rapid PCR purification system (Life Technologies). All DNAs
were extracted with fresh reagents in a PCR-dedicated clean
room. Sequencing was performed using the primers shown in
Table I and with an Applied Biosystems Inc. model 377 auto-
mated DNA sequencer with the BigDye cycle sequencing kit.
Detection of Molecular Clocks Among Protein Variants
The likelihood ratio test (LRT), a computer algorithm which
can detect molecular clocks in phylogenetic reconstructions (24,
25), was applied to alignments of TprK, TprJ, and the P1 protein
of Haemophilis influenzae. Phylogeny trees were constructed with
the maximum likelihood algorithm in PUZZLE (v4.0.2; refer-
ence 26) with and without a clock assumption, using the Dayhoff
model of substitution (27), gamma-distributed rate heterogeneity,
10,000 puzzling steps, and neighbor-joining reconstruction.
Results
Simultaneous Transcription of tpr Genes
As a starting point for our study, we used limiting dilu-
tion RT-PCR to assess the transcription of tprK relative to
other members of the tpr paralogous gene family and the
abundantly expressed flaA gene. Before performing these
experiments, we determined the amplification efficiency of
each primer pair with limiting dilutions of T. pallidum
DNA template. The resulting efficiency values (Table I)
were used to correct the densitometric analyses of the RT-
PCR products which were subsequently normalized to
flaA. As shown in Fig. 1, transcripts for all tpr genes were
detected, albeit at significantly lower levels than for flaA (all
P values ,0.001). The levels of transcript for tprs C/D, E,
G, H, J, and K were not significantly different (P . 0.05),
whereas transcripts for tprs A, B, F, I, and L were signifi-
cantly less abundant than that for tprK (P , 0.05).
Identification of the TprK Translational Start
In the T. pallidum genomic sequence (5), the translational
start for TprK was assigned to an ATG codon (Fig. 2 A).
The predicted 505 residue polypeptide does not possess an
NH2-terminal leader peptide, a prerequisite for OM local-
ization (16), but does contain a potential transmembrane
domain at amino acids 36 through 48. Based on this se-
quence, the PSORT algorithm assigns TprK to the cyto-
plasmic membrane. Centurion-Lara et al. (7), on the other
hand, proposed the GTG codon 75 bases downstream of
the ATG as the protein’s translational start. The resulting
480 residue protein contains a potential NH2-terminal ex-
port signal with a signal peptidase I cleavage site, consistent
with either a PP or OM location. Using this revised se-
quence, PSORT predicts either a PP or OM location with
the former heavily favored (scores of 0.927 and 0.28 for PP
and OM, respectively). Scores for known PP and OM pro-
teins, FlaA (PP 0.783, OM 0.221) and E. coli OmpF (PP
0.381, OM 0.944), support the algorithm’s predictive ca-
pacity. As the GTG start would allow TprK to potentially
reside in the OM and the ATG start would preclude an
OM localization, we next sought to determine the correct
translational start of the protein. The low abundance of the
native protein precluded obtaining NH2-terminal sequence
by automated Edman degradation. As an alternative strat-
egy, we generated chimeras in which the tprK sequence
distal to the leader peptide/transmembrane domain was
fused in-frame with an alkaline phosphatase reporter con-
struct lacking a leader peptide (19; Fig. 2). The chimeras
contained decreasing lengths of upstream sequence such
that the shortest insert (tprK-phoA3) began downstream of
the ATG start predicted by Fraser et al. (5), but upstream of
the GTG start predicted by Centurion-Lara et al. (7).
Moreover, by cloning these constructs in both orientations
relative to the lac promoter of pBluescript, we reasoned
that we also would be able to identify any autonomously
functioning TprK promoter(s). To ensure that the transla-
tion of PhoA fusions could initiate only from within TprK
sequences, all three constructs contained either naturally
occurring or engineered stop codons in-frame with the
vector-encoded LacZ a-peptide. In the SK orientation
(transcription driven by the lac promoter), all of the fusions
expressed PhoA activity (Fig. 2 B), strongly supporting the
translational start assigned by Centurion-Lara et al. (7) and
the presence of an NH2-terminal leader peptide. In the KS
orientation (transcription driven by the native promoter),
fusions TprK-PhoA1 and TprK-PhoA2 expressed PhoA
activity, whereas fusion TprK-PhoA3, which contains only
15 bp of sequence upstream of the GTG codon, did not.
This result indicates that the 78 bp of DNA deleted from
TprK-PhoA3 relative to TprK-PhoA2 contains an autono-
mous promoter. Indeed, consensus 235 and 210 pro-
Figure 1. Quantitation of flaA and tpr transcript levels. Reactions were
performed with limiting dilutions of RNA template and the RT-PCR
primers listed in Table I; note that tprC and tprD are identical genes. Neg-
ative controls (RT-PCR of H2O and PCR of RNA template) yielded no
signal whereas PCR amplification of DNA produced the same sized
product as RT-PCR of RNA (data not shown). Densitometric values of
resolved products were obtained within the linear range of amplification,
corrected for primer efficiency (Table I), and normalized to the flaA value
obtained with the same amount of RNA. Column values represent
means 6 SEM, and asterisks indicate values significantly different than
that of tprK (P , 0.05, Student’s t test).1020 The Periplasmic Protein TprK Is Not Protective
moter elements with a 17-bp spacer were identified within
this stretch; immediately upstream from the GTG start
codon is a consensus ribosomal binding site (Fig. 2 B).
Localization of Native TprK
Abs to TprK Do Not Promote Opsonization of Virulent
Treponemes. Having shown that TprK contains a func-
tional signal peptide, we next sought evidence that this
protein is exposed to the extracellular milieu. To detect
surface-exposed TprK, we assayed the ability of rabbit anti-
TprK Ab to opsonize spirochetes for phagocytosis by rabbit
peritoneal macrophages. In comparison with NRS, IRS
significantly (P , 0.05) enhanced phagocytosis of motile
treponemes, as reported previously (7, 13, 22). In contrast,
sera pooled (or tested individually) from TprK-immunized
animals did not promote phagocytosis (Fig. 3 A). We con-
sidered the possibility that anti-TprK Ab in IRS promote
opsonophagocytosis but that these Abs differ qualitatively
from those elicited by immunization with rTprK. Conse-
quently, we first determined whether the IRS used for the
opsonophagocytosis assays contains anti-TprK Ab. Com-
pared with NRS, significant (P , 0.05) immunoreactivity
against full-length rTprK was detected in the IRS by
ELISA (Fig. 3 A, inset) and by immunoblot (data not
shown), indicating that the protein does generate a hu-
moral immune response during infection and that Ab de-
rived from infection recognize rTprK. Not surprisingly, Ab
levels were much greater in sera from the TprK-immu-
nized animals (P , 0.001). Equivalent results were ob-
tained when the central domain was used as Ag (data not
shown). The opsonization assays then were repeated using
IRS from which the anti-TprK Ab had been adsorbed (Fig.
3 B, inset). No significant differences in the opsonic activi-
ties of IRS and the same IRS depleted of anti-TprK Ab
were observed (Fig. 3 B). When decreasing concentrations
of sera were used to eliminate the possibility that trace
amounts of residual anti-TprK Ab contributed to the op-
sonic activity of the adsorbed IRS, no significant differ-
ences were observed at comparable dilutions (Fig. 3 B).
TprK Is Ab Inaccessible in Intact Treponemes. As our op-
sonization assays failed to indicate surface exposure of
TprK, we used an alternate strategy, immunofluorescence
microscopy of spirochetes encapsulated in agarose beads, to
examine the cellular location of TprK (13, 17). This highly
sensitive technique preserves the integrity of the fragile T.
pallidum OM during surface immunolabeling studies.
Moreover, PP proteins can be detected by permeabilizing
the OM to Ab with low concentrations of nonionic deter-
gent. To better distinguish between intact and disrupted
organisms, we developed a modified procedure in which
encapsulated treponemes were probed simultaneously with
rat anti-TprK antisera and rabbit Ab directed against the PP
endoflagella (TpEf). In the absence of detergent, 90% of
the treponemes were intact (indicated by a lack of labeling
with anti-TpEf Ab), whereas all detergent-treated organ-
isms had disrupted OMs. As expected from the low levels
of tprK mRNA, detection of TprK required the use of two
sequential conjugates, whereas TpEf was readily detected
with a single conjugate. In three separate experiments in-
volving a total of 1,200 organisms, not a single intact or-
ganism was labeled with anti-TprK Ab. Every spirochete
labeled by anti-TprK Ab had a disrupted OM. Signifi-
cantly, every disrupted spirochete was labeled with anti-
TprK Ab suggesting that TprK is expressed by all trepo-
nemes. Representative micrographs are shown in Fig. 4.
The OM Protects TprK from PK. Although the above
results were most consistent with TprK being PP, an alter-
native explanation is that our antisera lacked Abs against
surface-exposed epitopes. For this reason, we also em-
ployed an Ab-independent method, PK accessibility, to as-
Figure 2. Identification of the TprK translational start and signal peptide. (A) Relevant features of the upstream DNA and 59 coding region of tprK and
the resulting NH2 terminus of the protein. Bold amino acids (M and V) indicate the TprK translational starts predicted by Fraser et al. (reference 5) and
Centurion-Lara et al. (reference 7). TIGR, The Institute for Genomic Research; C.L., Centurion-Lara et al. Asterisks indicate stop codons; nucleotide (nt)
and amino acid (AA) sequences not shown are indicated by I-bars and two-tailed arrows. (B) Diagrams of the tprK-phoA plasmids and the PhoA activities
they encode. With the exception of the engineered 59 TGA stop codon of tprK-phoA3, the diagrams in B correspond to the tprK sequence shown in A.1021 Hazlett et al.
sess the cellular location of TprK. As shown in Fig. 5, ex-
posure of motile T. pallidum to PK had no discernible effect
on the abundance of either TprK or the PP proteins Tp47
and FlaA. In contrast, permeablization of the OM with
0.01% Triton X-100 rendered all three proteins susceptible
to proteolytic digestion.
TprK Is Not an Integral Membrane Protein. As noted ear-
lier, PSORT predicts that TprK is PP, whereas TMpred
predicts that the protein has a cytoplasmic membrane–
spanning domain. Although OM and PP proteins are diffi-
cult to distinguish at the sequence level, they possess dis-
tinctly different physical properties; membrane proteins are
amphiphilic whereas PP proteins are hydrophilic. There-
fore, we next used Triton X-114 phase partitioning (13,
28, 29) to determine whether TprK possesses the am-
phiphilicity characteristic of an integral membrane protein.
Freshly harvested T. pallidum, solubilized in 2% Triton
X-114, was phase partitioned and the resulting fractions
were analyzed by immunoblot with Ab directed against ei-
ther TprK or Tp47. As reported previously (13, 29), ap-
proximately half of the Tp47 remained associated with the
insoluble material, whereas the remainder was detected ex-
clusively in the detergent-enriched phase (Fig. 6). In con-
trast, both rat anti-TprK antisera (Fig. 6) and the anti-TprK
mAb 1-7H11.1G6 (data not shown) recognized a 47-kD
polypeptide in the aqueous phase (Fig. 6), indicating that
TprK is not an integral membrane protein. This result also
indicates that the TprK leader peptide is cleaved because
proteins with uncleaved leader peptides partition into the
detergent-enriched phase (1, 14).
Immunization with TprK Does Not Confer Protective Immunity 
or Select for TprK Sequence Variants
Despite the evidence that TprK is periplasmic, an exam-
ination of its protective capacity appeared to be warranted in
light of the previous report of TprK-induced partial protec-
tion (7). In two independent experiments involving a total
of 12 rabbits, the time course for lesion development and
resolution and the gross appearance of lesions were indistin-
guishable between 6 TprK-immunized, and 6 control ani-
mals. Typical examples of lesion development are shown in
Fig. 7. TprK immunization also had no discernible effect on
the presence of spirochetes within tissues. In the first exper-
iment, spirochetes were recovered by RIT from spleen
and/or lymph nodes from one of the two TprK-immu-
nized and one of the two unimmunized rabbits. In the sec-
ond experiment, lesion aspirates from two to three sites on
each animal were obtained for darkfield microscopy 24 and
31 d after challenge. On day 24, seven of eight aspirates
from the TprK-immunized animals were darkfield positive
as opposed to eight of eight from the sham-immunized
controls. All aspirates were darkfield positive on day 31.
Figure 3. TprK is not an opsonic target in intact T. pallidum. (A) Phago-
cytosis of virulent treponemes by macrophages in the presence of 10%
NRS, IRS, and rabbit anti-TprK (anti-TprK) antisera. (B) Opsonic po-
tentials of 10% NRS and decreasing concentrations of IRS and the same
IRS depleted of anti-TprK Ab. Asterisks in panel A indicate values signif-
icantly different those of NRS; in panel B asterisks indicate values signifi-
cantly different from those obtained with the same concentration of IRS.
In both panels, phagocytosis data are the mean percentage of cells
(6SEM) with phagocytosed T. pallidum (n 5 3). Panel insets indicate the
levels of seroreactivity (mean OD 6 SEM) against rTprK. Differences
where considered significant by the Student’s t test when P , 0.05, 0.01,
or 0.001 (one, two, or three asterisks, respectively).
Figure 4. TprK is inaccessible to anti-TprK Ab in intact T. pallidum.
Agarose-encapsulated spirochetes were simultaneously probed with rat
anti-TprK and rabbit anti-TpEf Ab in the absence or presence of 0.05%
Triton X-100. Treponemes were subsequently incubated with biotiny-
lated goat anti–rat IgG followed by incubation with streptavidin-Alexa®
488 and goat anti–rabbit conjugated to Alexa® 546. Panels on the left
show encapsulated spirochetes by darkfield microscopy; panels on the
right show immunofluorescence of the same treponemes.1022 The Periplasmic Protein TprK Is Not Protective
As noted earlier, the discovery of variant tprK genes
among geographically disparate T. pallidum strains and
within some treponemal subpopulations has fueled specula-
tion that host immune responses select for TprK sequence
variants (8, 9). If this were the case, then TprK “escape
variants” should be overrepresented among treponemes re-
covered from TprK-immunized animals. To examine this
issue, we PCR amplified and sequenced tprK genes from
our challenge strain (Nichols-Farmington), the isolates re-
covered by RIT in experiment one, and the spirochetes in
the lesion aspirates from experiment two. As described in
Materials and Methods, extensive precautions were taken
to avoid PCR artifacts which would confound this analysis.
As is the case for all TprK proteins reported to date, the
Nichols-Farmington TprK was not an exact match for any
other polypeptide in the databases (Fig. 8 A, and not
shown). However, it was most similar to the Nichols-Seat-
tle and Nichols-Houston TprKs with 97% amino acid
identity to each. The 12 amino acid differences (10 substi-
tutions and 2 deletions) between the Farmington and Seat-
tle orthologs are located in four of the seven recently de-
scribed TprK variable regions (i.e., V1, V3, V6, and V7;
Fig. 8 A; references 8 and 9). The amino acid identity
of the Nichols-Farmington TprK with the remaining
orthologs in the databases ranged from 87 to 91% with the
differences mapping to the seven variable regions. It is
noteworthy that the PSORT algorithm heavily favors a PP
location for all TprK orthologs (Fig. 8 A and data not
shown). Downstream of the tprK coding region, the
Nichols-Farmington strain contained the same 67-bp dele-
tion reported for the Nichols-Seattle and Bal7 strains but
which is absent from all other strains examined thus far
(data not shown; references 8 and 9). In contrast to the het-
erogeneity among the geographically distinct TprK pro-
teins, the TprK sequences of treponemes recovered from
five different TprK-immunized animals were identical to
that of Nichols-Farmington (Fig. 8 B). The sole sequence
variant, with two amino acid changes in region V7, was re-
covered from an unimmunized control rabbit (Fig. 8 B).
As the above results suggested that tprK is not subject to
immunological pressure, we next used the LRT to deter-
mine whether the variation among TprK sequences is con-
sistent with evolutionary drift. LRT, a phylogenetic tool
used in molecular evolutionary biology, can determine
whether variation among related sequences has occurred at
a constant or at a discontinuous rate (24, 25). The hypoth-
esis underlying our LRT analysis of TprK was that proteins
subject to immunological pressure would show a discontin-
uous rate of change and therefore not display a molecular
clock. To assess this hypothesis, we tested for the presence
of molecular clocks in TprK, TprJ, and the H. influenzae P1
protein. TprJ is predicted by PSORT to be anchored to
the cytoplasmic membrane via an uncleaved leader peptide
(5, 7); a protein sequestered in this manner should not be
subject to immunological pressure. In this regard, TprJ has
been shown to be stable in T. pallidum Nichols for .1 yr
despite repeated passage in rabbits (30). P1 is an OM pro-
tein with surface-exposed hypervariable domains which are
known to be subject to immunological selection (31).
Consistent with our hypothesis, the molecular clock was
rejected for the immunologically driven variation of P1
(Table II). Both TprJ and TprK displayed a molecular
clock (Table II) indicating constant rates of change consis-
tent with evolutionary drift.
Figure 5. TprK is inaccessible
to PK in intact T. pallidum. Spi-
rochetes were left untreated, or
treated with PK (0.4 mg/ml)
with or without Triton X-100
(0.01%). Lysates were probed
with rat anti-TprK, anti-Tp47,
and anti-FlaA antiseras followed
by development using enhanced
chemiluminescence (TprK) or colorimetric (Tp47 and FlaA) methods.
Molecular masses (kD) are indicated on the left.
Figure 6. TprK does not pos-
sess the amphiphilicity typical of
integral membrane proteins. T.
pallidum was phase partitioned
using Triton X-114. Whole cells
(WC), Triton X-114–insoluble
material (I), the detergent-enriched (D), and the aqueous phases (A) were
subjected to immunoblot analysis with rat anti-TprK and anti-Tp47 anti-
sera. Molecular masses (kD) are indicated on the left.
Figure 7. Immunization with TprK does not protect against experi-
mental syphilis. Unimmunized and TprK-immunized rabbits were chal-
lenged by intradermal inoculation at six sites with 103 T. pallidum per site.
Black ink marks are visible between the erythemous lesions. Photographs
depict typical animals in one of two separate experiments involving a total
of 12 rabbits.1023 Hazlett et al.
Figure 8. Immunization with TprK does not select for TprK sequence variants. (A) Alignment of geographically distinct Nichols strain TprKs. UNC
indicates the University of North Carolina. The seven discrete regions of variability (V1–V7) are shown above the aligned proteins. (B) Alignment of
Nichols-Farmington TprK with the TprKs of treponemes recovered from five different TprK-immunized rabbits and one unimmunized rabbit which
had been challenged with Nichols-Farmington T. pallidum. The TprK of spirochetes recovered from an unimmunized rabbit displayed variability in the
V7 region. PSORT scores are shown at the COOH termini. Sequences of the tprK gene of Nichols-Farmington T. pallidum and of treponemes recov-
ered from challenged rabbits are available from GenBank/EMBL/DDBJ under accession nos. AF343915–AF343921.1024 The Periplasmic Protein TprK Is Not Protective
Discussion
Several years ago, in an effort to facilitate the identifica-
tion of syphilis vaccine candidates, we enumerated the fun-
damental properties which bona fide T. pallidum rare OM
proteins ought to possess (32). Many of these characteristics
are intrinsic to gram-negative bacterial OM proteins: a sig-
nal peptidase I–cleavable export signal, an absence of long
stretches of hydrophobic residues within the mature
polypeptide, an overall amphiphilic nature, and susceptibil-
ity to surface-specific labeling techniques. The remaining
properties, low abundance and poor immunogenicity, are
unique to T. pallidum and reflect the limited reactivity of
the spirochete’s surface with the specific Abs in human and
rabbit syphilitic sera (17, 20) and the paucity of intramem-
branous particles observed when the T. pallidum OM is ex-
amined by freeze-fracture electron microscopy (33). With
the availability of the bacterium’s genomic sequence and the
aid of computer algorithms, T. pallidum polypeptides now
can be rapidly screened for potential OM proteins. Never-
theless, such predictions still must be confirmed empirically
using techniques which examine both the protein’s physical
properties and its cellular location (32).
TprK meets some of these criteria and, therefore, is a vi-
able candidate OM protein. It is predicted (7), and has been
shown here, to have a signal peptide which is likely
cleaved. The mature polypeptide does not contain signifi-
cant stretches of hydrophobic residues. The relatively low
levels of transcript detected by RT-PCR, coupled with the
need for enhanced chemiluminescence in order to detect
the native protein on immunoblots, point to its low abun-
dance in T. pallidum. Also noteworthy was the meager
fourfold increase in rTprK-ELISA reactivity of IRS com-
pared with NRS, a result indicating that the protein is
poorly immunogenic during acquired experimental infec-
tion. Significantly, TprK is related to the T. denticola OM
protein, Msp (7). Despite these findings, TprK has both
computer-predicted and empirically revealed properties
which are irreconcilable with an OM location. As noted
earlier, PSORT scores for the protein heavily favor a PP
location. The observations that the protein has a functional
signal peptide, partitions into the Triton X-114 aqueous
phase, and becomes susceptible to Ab and PK only after
perturbation of the OM strongly indicate that TprK resides
entirely within the PP space.
To maximize the potential for observing TprK-mediated
protection, we immunized rabbits with the central domain
as well as an equivalent amount of the full-length protein.
Additionally, we used a 100-fold lower challenge dose (i.e.,
103 treponemes per site) than was used by Centurion-Lara
et al. (7), which should have biased the experiment in favor
of a protective effect. Nevertheless, in two independent ex-
periments we failed to observe any alteration of lesion de-
velopment after challenge of TprK-immunized rabbits.
How, then, can these observations be reconciled with the
previously reported partial protection results (7)? We can
only speculate that minor differences in challenge protocol
Table II. Likelihood Ratio Analysis for Molecular Clocks Among Protein Variants
Protein Variants* Log L0
‡ Log L1
‡ 22 Log L‡ df§ P value Molecular clocki
T. pallidum TprJ  Nichols-Houston 22213.24 22213.01 0.47 2 0.7923 Accepted
SS14 nos. 1–3
H. influenzae P1 BCH-3 22440.01 22428.80 22.43 7 0.0004 Rejected
BCH-2 
1-H-1085
22-H-1154
4-H-1094
13-H-1157
4-H-1093
T. pallidum TprK  Nichols-Houston 23580.59 23571.28 18.63 17 0.3500 Accepted
SS14 nos. 1–7
Bal 73-1 no. 134
Bal 7 no. 124, no. 126
Sea 81-4 no. 120, no. 121
Nichols-UNC nos. 1–7
*For the T. pallidum alignments, the Nichols-Houston sequences were used as out-groups, whereas the BCH-3 sequence was used as an out-group
for the H. influenzae P1 alignment.
‡As a molecular clock hypothesis is nested within a more general assumption of nonclock-like evolution, the LRT equation can be resolved to the
test value; 22( Log L), where Log L 5 Log L0 2 Log L1. Log L0 is the maximum likelihood value derived for a tree that assumes a molecular clock,
whereas Log L1 is the comparable value derived for a tree that allowed for nonclock-like rates of change.
§Degrees of freedom equals the number of sequences minus two.
iClock-like evolution was rejected at a statistical significance of P , 0.05.1025 Hazlett et al.
resulted in these conflicting levels of protection. Precedent
for such disparate findings is provided by another PP pro-
tein, the treponemal glycerophosphodiester phosphodi-
esterase (GlpQ) homologue. Like TprK, GlpQ was initially
identified as a candidate opsonic target by immunologically
screening an expression library in duplicate with IRS and
with a nonopsonic sera raised against heat-killed T. pallidum
(4, 7). Immunization with rGlpQ was reported to confer
partial protection to homologous T. pallidum challenge, al-
though, contrary to expectations, anti-rGlpQ Ab were not
opsonic (12). Subsequently, using techniques similar to
those described here, we demonstrated that native GlpQ is
a lipoprotein anchored to the PP leaflet of the cytoplasmic
membrane and that immunization with rGlpQ failed to in-
duce either opsonic Ab or protective immunity (13). Thus,
we can only reiterate that, in our hands, for two different
proteins, both the lack of opsonic activity and protective
immunity correlated with Ab inaccessibility.
As Abs do not have access to TprK within live T. palli-
dum, the tprK gene should not be subject to the immuno-
logical pressure applied to genes encoding surface-exposed
proteins. Consistent with this notion, the tprK gene re-
mained stable after challenge of rabbits with preexisting hu-
moral immunity to TprK. Significantly, variation of TprK
displays a molecular clock, whereas the immunologically
driven variation of the H. influenzae OM protein P1 does
not. As variation of TprK does not appear to be immuno-
logically driven, the significance of the TprK variable re-
gions (V1 to V7) remains to be determined. In light of our
findings, we postulate that this variability represents evolu-
tionary change in the regions of TprK in which strict se-
quence conservation is not critical for maintenance of the
protein’s physiological function(s).
As much of the thinking concerning TprK has been
guided by the protein’s homology with Msp, the finding that
Tprk is periplasmic raises an apparent conceptual inconsis-
tency. How can orthologs reside in different cellular com-
partments? Prior studies held that Msp was porin like, exten-
sively surface exposed, and formed hexagonal arrays in the T.
denticola OM (6). However, prompted by the discovery of
the Tpr family in T. pallidum, we recently reexamined the
membrane topology of Msp. In contrast to previous reports,
we found that (a) the T. denticola OM does not contain a
hexagonal array, (b) the array-like structure visualized in pre-
viously published electron micrographs (6) was most likely
the spirochete’s peptidoglycan sacculus, and (c) the majority
of the Msp molecule is periplasmic with only limited regions
protruding through the OM to the treponemal surface (15).
Based on these more recent findings, one can envision that
the significant amino acid differences between Msp and
TprK (26% identical, 39% similar) allow one or more small
domains of Msp to adopt the b-strand structure required for
OM insertion whereas TprK would lack the comparable se-
quences. Moreover, this minor variance in localization could
allow the presumably similar PP functions of Msp and TprK
to be maintained. Despite our findings for TprK, this formu-
lation suggests that other members of the Tpr family merit
further investigation as potential rare OM proteins. Although
preliminary PhoA fusion analyses indicates that all but TprA,
TprB, and TprH possess NH2-terminal export signals (data
not shown), most of the remaining Tpr proteins are pre-
dicted to reside in the PP either free or anchored to the cy-
toplasmic membrane by an uncleaved leader peptide (5).
TprF and TprI appear to be notable exceptions in that they
have favorable PSORT scores for OM localization.
The regions of homology among the tpr genes, coupled
with the putative surface exposure of a subset of Tpr pro-
teins, has invited speculation that the Tprs represent a re-
combination-based system of antigenic variation which
contributes to the relapsing nature of syphilis (5, 7). How-
ever, the existing data do not support this notion. Unlike
other recombination-based antigenic variation systems in
which a single allele is expressed at a given time, both we
and others (10) have found that all the tpr genes are simul-
taneously expressed albeit at different levels. Although one
could postulate that this represents a mixture of subpopula-
tions each expressing a different Tpr, our finding that every
disrupted spirochete examined by immunofluorescence
was labeled by anti-TprK Abs is inconsistent with this hy-
pothesis. Moreover, although recombination between sub-
sets of the tprs is not conceptually impossible, multiple se-
quences of tprJ and tprK, which share homology with tprs G
and E, and tprs A, B, H, L, respectively, show no evidence
of recombination among these genes (8, 9). Furthermore,
we have shown that tprK remains entirely unaltered despite
propagation in TprK-immunized animals. To search for
chimeric tpr genes, we have begun using long-range PCR
with primers specific for the upstream and internal se-
quences in a checkerboard pattern (i.e., tprA upstream for-
ward with tprB internal reverse). With a sensitivity of 1 re-
combinant gene in 10,000 spirochetes, preliminary results
offer no evidence for tpr recombination in either Nichols-
Farmington T. pallidum or in treponemes recovered from
challenged animals (unpublished observations).
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